Imaging tests for suspected bone or soft-tissue tumors
Part of Bones, joints & muscles, Cancer clinical trials.
This trial studies new imaging methods to better identify and stage (find how far it has spread) suspected bone or soft-tissue tumors. It may help your care team choose the most accurate next steps based on your scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected tumor in the bone or in soft tissue
- You are scheduled for imaging to characterize and stage it (initial evaluation)
- You are not pregnant
- You are not breastfeeding
- Your kidneys work well enough for the needed scan process
- You can safely have MRI and/or CT, and have no contraindications
- You have not had surgery or treatment on the tumor area being evaluated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial looks at how two test approaches (an MRI-based scan and blood tests) work in people with a larger, grade 2 or 3 soft tissue sarcoma. It may help researchers learn better ways to measure the disease and guide care.
This trial uses MRI scans to create a model that may predict if a musculoskeletal tumor is spreading. It aims to help doctors decide on the best surgical treatment.
This study tests whether MRI scans can replace CT scans to map bone tumors and plan surgery. If successful, it may allow some patients to avoid CT radiation.
This study tests a new way to make MRI scans look like CT scans to find bone damage from multiple myeloma. You may join if you have just been diagnosed or if your disease came back after strong treatments, and you need bone imaging for staging.
This trial studies a way of planning and delivering radiation using MRI pictures to help target tumors more accurately. It may benefit people by improving how radiation is aligned, and it’s being tested for safety and effectiveness compared with the usual CT-based planning.
This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.
Hear when a new Soft Tissue Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.